Skip to content

Anesthetic Efficacy of Modified Infiltration Technique in mandibular molars

Primary and Supplementary Anesthetic Efficacy of Modified Infiltration Technique with 4% Articaine versus Inferior Alveolar Nerve Block with 2% lidocaine in Mandibular molars with Irreversible Pulpitis: A Randomized Clinical Trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200301046656N1
Enrollment
84
Registered
2021-01-21
Start date
2021-01-31
Completion date
Unknown
Last updated
2021-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Irreversible pulpitis. Irreversible pulpitis

Interventions

Intervention 1: Intervention group: Subperiosteal group. In this group, patients will receive an anesthetic subperiosteal injection of 1.8 mL articaine 4% with 1:100.000 epinephrine with an extra shor

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: having a first/second mandibular molar tooth diagnosed with irreversible pulpitis absence of any systemic disease absence pregnancy or nursing for female participants occurrence of periapical lesion on preoperative radiograph(s) absence of any inflammation or lesion/wound in anesthetic injection's area absence of a history of any allergic reaction to the materials used in the present study

Exclusion criteria

Exclusion criteria: more than 0.5 mm mobility on occluso-gingival and/or bucco-lingual and/or mesio-distal direction. taking analgesic medications less than a day before the beginning of the treatment absence of vital pulpal tissue upon access cavity preparation

Design outcomes

Primary

MeasureTime frame
Patient's perceived pain score. Timepoint: before the injection, while injecting, access cavity preparation, and initial filing. Method of measurement: 170 mm Heft Parker Visual anlogue scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNazanin Zargar

Shahid Beheshti University of Medical Sciences

nzargar48@gmail.com+98 21 2217 5350

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026